Quantum Biopharma (QNTM)
NASDAQ:QNTM
Holding QNTM?
Track your performance easily

Quantum Biopharma (QNTM) Financial Statements

444 Followers

Quantum Biopharma Financial Overview

Quantum Biopharma's market cap is currently ―. The company's EPS TTM is $-12.575; its P/E ratio is -0.40; Quantum Biopharma is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-2.69. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -7.11M$ -7.95M$ -5.44M
EBITDA--$ -5.97M$ -6.82M$ -4.34M
Net Income Common Stockholders--$ -7.13M$ -4.42M$ -5.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.51M$ 16.98M$ 23.78M$ 31.62M$ 28.57M
Total Assets$ 17.47M$ 38.41M$ 43.58M$ 51.17M$ 55.71M
Total Debt$ 339.20K$ 516.42K$ 556.97K$ 508.39K$ 552.50K
Net Debt$ -3.17M$ -16.46M$ -23.22M$ -31.11M$ -28.02M
Total Liabilities$ 4.57M$ 7.87M$ 7.44M$ 8.59M$ 8.95M
Stockholders Equity$ 13.24M$ -115.66M$ 36.14M$ 42.58M$ 46.76M
Cash Flow-
Free Cash Flow--$ -7.61M$ -9.40M$ -5.36M
Operating Cash Flow--$ -7.52M$ -9.40M$ -5.09M
Investing Cash Flow--$ -96.92K$ 12.72M$ -106.59K
Financing Cash Flow--$ -257.77K$ -275.25K$ -1.49M
Currency in USD

Quantum Biopharma Earnings and Revenue History

Quantum Biopharma Debt to Assets

Quantum Biopharma Cash Flow

Quantum Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis